skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Financial Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

IFI Logo
Search Icon RecommendationseCommerce StoreProduct loginProductLogin
Global Search Configuration

Positive vaccine news keeps flows buoyant in mid-November

With hopes rising that two, if not three, vaccines that are over 90% effective against the COVID-19 virus will be available for use by year’s end, US equity markets hit a new record high and EPFR-tracked Equity Funds continued to enjoy strong inflows during the week ending Nov. 18. But investors also paid more attention to the economic damage that may occur between the peak of the pandemic’s second wave and sufficiently widespread vaccination, especially in Europe, which capped the latest week’s Equity Fund inflows at 60% of the previous week’s record-setting total.

Sentiment towards emerging markets, anchored by China’s return to growth, remains on the mend and has picked up a tailwind from expectations that 2021 will see more travel thanks to the deployment of vaccines, thereby boosting tourism and oil prices. Emerging Markets Equity Funds posted their ninth consecutive inflow and Emerging Markets Bond Funds their 19th in the past 21 weeks. Emerging Markets Money Market Funds are also enjoying solid inflows and are on course to set a new full-year record, with Asia ex-Japan Funds seeing the biggest inflows in cash terms and Latin America Equity Funds in % of AUM terms.

 

Global Navigator

Global Navigator 

For more insight subscribe here.

Any questions? Speak to a specialist

Would you like to request sample data or analysis from Informa Financial Intelligence? 

Request a callback
See how our tailored solutions can help you gain a competitive advantage: 
Request a free demo